NCT07424521

Brief Summary

Menopause is a natural biological process characterized by the permanent cessation of the menstrual cycle in women. Hormonal changes associated with menopause commonly lead to mood swings, anxiety, depression, stress, and decreased sleep quality in women. While the current literature indicates that mindfulness-based interventions offer potential benefits in alleviating psychological and physical symptoms in postmenopausal women, the limited number of studies in the literature and methodological differences suggest a need for more randomized controlled trials in this area. The aim of this study is to examine the effect of mindfulness-based exercises on psychosomatic complaints such as anxiety, depression, and sleep quality in postmenopausal women. Designed as a randomized controlled experimental study, it was planned to include at least 20 women in the early postmenopausal period residing in Istanbul and Izmir between March and June 2026. The women included in the study will be randomized into Group 1 (n=10), which will perform mindfulness-based exercises, and Group 2 (n=10), which will receive no intervention as usual. The STAI I-II Form State and Trait Anxiety Scale and Beck Anxiety Inventory will be used to assess state and anxiety level, the Beck Depression Scale for depression level, and the Pittsburgh Sleep Quality Scale for sleep quality. Continuous variables will be presented as mean ± standard deviation, and qualitative variables as number and percentage (%). If parametric test assumptions are met, the Independent Samples t-test will be used to compare independent groups, and the Paired Samples t-test will be used to compare dependent groups. If parametric test assumptions are not met, the Mann-Whitney U test will be used to compare independent groups, and the Wilcoxon test will be used to compare dependent groups. Statistical significance will be set at p≤0.05. This study is expected to contribute to the literature by providing evidence-based data on the effectiveness of mindfulness-based exercises on common psychological symptoms in the postmenopausal period.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 20, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

2 months

First QC Date

February 14, 2026

Last Update Submit

February 14, 2026

Conditions

Keywords

mindfulnesspostmenopausaldepressionsleep qualityanxiety

Outcome Measures

Primary Outcomes (4)

  • The STAI I-II State and Trait Anxiety Scale

    The STAI I-II State and Trait Anxiety Scale is a psychological inventory consisting of 40 self-report items that measure participants' anxiety levels. It measures two types of anxiety: state anxiety and trait anxiety. Total scores from both scales range from 20 to 80. Higher scores are directly proportional to higher anxiety levels. Validity and reliability studies were conducted by Öner and LeCompte in 1977.

    Baseline (pre-intervention) and Week 8 (post-intervention)

  • Beck Anxiety Inventory

    Beck Anxiety Inventory (BAI) is a 21-item self-assessment scale designed to measure an individual's anxiety level. Each item is scored from 0 to 3, with a maximum total score of 63. Scores between 0 and 7 indicate minimal anxiety, 8-15 mild anxiety, 16-25 moderate anxiety, and 26 or higher indicates severe anxiety. The Turkish validity and reliability study of the scale was conducted by Ulusoy et al.

    Baseline (pre-intervention) and Week 8 (post-intervention)

  • Beck Depression Inventory

    Beck Depression Inventory (BDI): Developed in 1961 by Beck and colleagues, this is a 21-item self-assessment scale used to measure the level of depressive symptoms. Each item on the scale is worth 0 to 3 points, with a maximum total score of 63. A score of 0-13 indicates no depression, 14-19 indicates mild depression, 20-28 indicates moderate depression, and 29 points and above indicates severe depression. The Turkish validity and reliability study of the scale was conducted by Hisli in 1989.

    Baseline (pre-intervention) and Week 8 (post-intervention)

  • The Pittsburgh Sleep Quality Scale

    The Pittsburgh Sleep Quality Scale is a 19-item self-report scale that assesses participants' sleep quality and disturbances over a one-month period. It includes components such as subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, sleep medication use, and daytime dysfunction. Each component is scored on a scale of 0-3. The total score of the 7 components gives the overall scale score. The total score ranges from 0 to 21. A total score greater than 5 indicates poor sleep quality. The Turkish validity and reliability study of the scale was conducted by Ağargün et al. in 1996.

    Baseline (pre-intervention) and Week 8 (post-intervention)

Study Arms (2)

Mindfulness group

EXPERIMENTAL

This represents the group that will receive mindfulness-based training for 8 weeks.

Other: Mindfulness-Based Stress Reduction Training

Control group

NO INTERVENTION

This represents the control group, where no intervention is applied, as is the case in routine training.

Interventions

Participants will be asked to attend standard group classes for one hour, six days a week. Meditation-based techniques will include breathing exercises, sitting meditations, and body scans. In week 6 of the program, individuals will undergo an eight-hour retreat, and will continue with the standard exercises for the remaining weeks. The goal of practicing mindfulness-based techniques daily is to ensure their effectiveness as a sustainable, lifelong intervention.

Mindfulness group

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly postmenopausal women will be included because the study focuses on physiological and functional changes specific to the postmenopausal period
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteering to participate in the study
  • Being in the early postmenopausal period (no more than 8 years have passed since menopause)
  • Having experienced natural menopause
  • Having had at least one pregnancy
  • Residing in Istanbul or Izmir provinces

You may not qualify if:

  • History of trauma or illness that would prevent exercise
  • Having received hormone replacement therapy
  • Being involved in a different exercise program
  • Presence of a severe cardiopulmonary, orthopedic, or neurological disease
  • Presence of a psychological or psychiatric diagnosis
  • Presence of physical discomforts such as severe dizziness
  • Cooperation problems and incompatibility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

DepressionSleep Initiation and Maintenance DisordersAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • İrem Çetinkaya, PhD

    Haliç University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

İrem Çetinkaya, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 14, 2026

First Posted

February 20, 2026

Study Start

March 1, 2026

Primary Completion

May 1, 2026

Study Completion

June 1, 2026

Last Updated

February 20, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share